STOCKHOLDERS EQUITY (Tables)

3 Months Ended

Dec. 31, 2020

STOCKHOLDERS EQUITY

Stock options, stock bonuses and compensation granted by the Company

Name of Plan	Total Shares Reserved Under Plans		Shares Reserved for Outstanding Options		Shares Issued		Remaining Options/Shares Under Plans
Incentive Stock Options Plans		138,400		85,895		N/A		213
Non-Qualified Stock Option Plans		9,987,200		8,527,787		N/A		1,201,832
Stock Bonus Plans		783,760		N/A		348,660		435,067
Stock Compensation Plans		634,000		N/A		150,695		464,895
Incentive Stock Bonus Plan		640,000		N/A		614,500		25,500

Underlying share information for equity compensation plans as of September 30, 2020 is as follows:

Name of Plan	Total Shares Reserved Under Plans		Shares Reserved for Outstanding Options		Shares Issued		Remaining Options/Shares Under Plans
Incentive Stock Option Plans		138,400		85,895		N/A		213
Non-Qualified Stock Option Plans		9,987,200		8,567,808		N/A		1,167,166
Stock Bonus Plans		783,760		N/A		345,096		438,631
Stock Compensation Plans		634,000		N/A		150,695		464,895
Incentive Stock Bonus Plan		640,000		N/A		616,500		23,500

Stock option activity

	Three Months Ended December 31,
	2020		2019
Options granted		7,500		1,000
Options exercised		5,300		-
Options forfeited		42,166		-
Options expired		55		36

Stock-based compensation expense

	Three months Ended December 31,
	2020		2019
Employees	$	3,296,309	$	1,800,225
Non-employees	$	248,660	$	155,740

Derivative liabilities, warrants and other options

Warrant/Options	Issue Date	Shares Issuable upon Exercise of Warrants/ Options		Exercise Price		Expiration Date	Reference
Series N	8/18/2008		85,339	$	3.00	8/18/2021		2
Series UU	6/11/2018		93,603	$	2.80	6/30/2021		2
Series X	1/13/2016		120,000	$	9.25	7/13/2021		2
Series Y	2/15/2016		26,000	$	12.00	8/15/2021		2
Series ZZ	5/23/2016		20,000	$	13.75	5/18/2021	*
Series BB	8/26/2016		16,000	$	13.75	8/22/2021	*
Series Z	5/23/2016		264,000	$	13.75	11/23/2021	*
Series FF	12/8/2016		68,048	$	3.91	12/1/2021	*
Series CC	12/8/2016		143,643	$	5.00	12/8/2021		1
Series HH	2/23/2017		200	$	3.13	2/16/2022	*
Series AA	8/26/2016		200,000	$	13.75	2/22/2022	*
Series MM	6/22/2017		797,633	$	1.86	6/22/2022	*
Series NN	7/24/2017		348,842	$	2.52	7/24/2022	*
Series RR	10/30/2017		417,649	$	1.65	10/30/2022	*
Series SS	12/19/2017		326,064	$	2.09	12/18/2022	*
Series TT	2/5/2018		361,564	$	2.24	2/5/2023		2
Consultants	7/28/2017 - 11/18/2020		15,000	$	2.18-11.61	11/17/2022 - 7/27/2027		3

Tabular disclosure of derivative liabilities at fair value

	December 31, 2020		September 30, 2020
Series W warrants	$	-	$	73,570
Series Z warrants		929,539		1,207,902
Series ZZ warrants		23,177		75,044
Series AA warrants		748,404		1,082,212
Series BB warrants		34,541		65,173
Series CC warrants		1,053,517		1,259,712
Series HH warrants		1,749		2,000
Total warrant liabilities	$	2,790,927	$	3,765,613

Schedule of gains and (losses) on derivative liabilities

	2020		2019
Series V warrants	$	-	$	555,031
Series W warrants		73,570		151,374
Series Z warrants		278,363		10,549
Series ZZ warrants		51,867		14,847
Series AA warrants		333,808		64,978
Series BB warrants		30,632		(431	)
Series CC warrants		164,345		(22,681	)
Series FF warrants		-		(7,189	)
Series HH warrants		251		(82	)
Series JJ warrants		-		(130	)
Series LL warrants		-		243
Net gain on warrant liabilities	$	932,836	$	766,509

Warrants recorded as equity exercised

Warrants	Warrants Exercised		Exercise Price		Proceeds
Series OO		10,000	$	2.52	$	25,200
Series SS		22,632	$	2.09		47,301
Series TT		100,628	$	2.24		224,600
		132,900			$	297,101